Sun Pharmaceutical Industries Limited (BOM:524715)
1,842.00
-22.00 (-1.18%)
At close: Sep 11, 2026
BOM:524715 Revenue
Sun Pharmaceutical Industries had revenue of 153.00B INR in the quarter ending June 30, 2026, with 10.46% growth. This brings the company's revenue in the last twelve months to 599.11B, up 11.41% year-over-year. In the fiscal year ending March 31, 2026, Sun Pharmaceutical Industries had annual revenue of 584.62B with 11.19% growth.
Revenue (ttm)
599.11B
Revenue Growth
+11.41%
P/S Ratio
7.37
Revenue / Employee
12.75M
Employees
47,000
Market Cap
4.41T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 584.62B | 58.84B | 11.19% |
| Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
| Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
| Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
| Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 331.19B |
| Lupin | 299.67B |
| Torrent Pharmaceuticals | 157.23B |
| Jubilant Pharmova | 86.08B |
| Abbott India | 70.04B |
| Granules India | 56.32B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| GlaxoSmithKline Pharmaceuticals | 39.55B |
Sun Pharmaceutical Industries News
- 11 days ago - Cipher Pharmaceuticals Secures Court Confirmation Of Arbitration Award - Nasdaq
- 11 days ago - Sun Pharma offers US cheaper drug supply - The Times of India
- 12 days ago - India's Sun Pharma, 8 Drugmakers Sign Pricing Deals With Team Trump - NDTV
- 5 weeks ago - Sun Pharma withdraws 11 eye medicines - The Times of India
- 6 weeks ago - Sun Pharmaceutical Industries Transcript: Q1 26/27 - Transcripts
- 6 weeks ago - Sun Pharmaceutical Industries Quarterly report: Q1 2027 - Filings
- 6 weeks ago - Sun Pharma's quarterly profit jumps on strength in specialty medicines - Reuters
- 6 weeks ago - Earnings To Watch: Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) Q1 2027 -- GF Value Sees ... - GuruFocus